All times are listed in CEST (Central European Summer Time)

 

Displaying One Session

View
ESMO Colloquium

ESMO Colloquium supported by Eli Lilly & Company - Precision oncology beyond EGFR/ALK for NSCLC in 2023: Test, target, manage

Date
Thu, 30.03.2023
Time
09:15 - 10:45
Room
Auditorium 4
Chairs
  • S. Peters (Lausanne, Switzerland)
  • B. Besse (Villejuif, France)
Session Description

Access the ESMO COLLOQUIUM EVALUATION FORM

To view the Session Chair DOI click here

ESMO Colloquium

Introduction: Summary data on the ESMO Survey on Biomolecular Technology Availability

Lecture Time
09:15 - 09:20
Speakers
  • S. Peters (Lausanne, Switzerland)
Session Name
ESMO Colloquium supported by Eli Lilly & Company - Precision oncology beyond EGFR/ALK for NSCLC in 2023: Test, target, manage (ID 23)
Room
Auditorium 4
Date
Thu, 30.03.2023
Time
09:15 - 10:45
Authors
  • S. Peters (Lausanne, Switzerland)
ESMO Colloquium

Current indications of precision therapeutics in advanced oncogene-addicted NSCLC beyond EGFR and ALK: Efficacy, safety, value

Lecture Time
09:20 - 09:35
Speakers
  • B. Besse (Villejuif, France)
Session Name
ESMO Colloquium supported by Eli Lilly & Company - Precision oncology beyond EGFR/ALK for NSCLC in 2023: Test, target, manage (ID 23)
Room
Auditorium 4
Date
Thu, 30.03.2023
Time
09:15 - 10:45
Authors
  • B. Besse (Villejuif, France)
ESMO Colloquium

The quest for optimal integration of biomarker testing by tissue NGS in the care pathway: Analytics, availability and reporting of actionable vs non-actionable aberrations

Lecture Time
09:50 - 10:05
Speakers
  • J. Hernandez-Losa (Barcelona, Spain)
Session Name
ESMO Colloquium supported by Eli Lilly & Company - Precision oncology beyond EGFR/ALK for NSCLC in 2023: Test, target, manage (ID 23)
Room
Auditorium 4
Date
Thu, 30.03.2023
Time
09:15 - 10:45
Authors
  • J. Hernandez-Losa (Barcelona, Spain)
ESMO Colloquium

Q&A

Lecture Time
10:05 - 10:15
Speakers
  • S. Peters (Lausanne, Switzerland)
Session Name
ESMO Colloquium supported by Eli Lilly & Company - Precision oncology beyond EGFR/ALK for NSCLC in 2023: Test, target, manage (ID 23)
Room
Auditorium 4
Date
Thu, 30.03.2023
Time
09:15 - 10:45
Authors
  • S. Peters (Lausanne, Switzerland)
ESMO Colloquium

The quest for optimal positioning of liquid biopsies in the workup of patients with NSCLC: When, for what and how often

Lecture Time
10:30 - 10:45
Speakers
  • U. Malapelle (Napoli, Italy)
Session Name
ESMO Colloquium supported by Eli Lilly & Company - Precision oncology beyond EGFR/ALK for NSCLC in 2023: Test, target, manage (ID 23)
Room
Auditorium 4
Date
Thu, 30.03.2023
Time
09:15 - 10:45
Authors
  • U. Malapelle (Napoli, Italy)
ESMO Colloquium

Highlighting the value of Molecular Tumour Boards: Presentation of two patient cases with oncogene-addicted NSCLC, summary of clinical evidence and insights in molecular profiling/interpretation

Lecture Time
10:45 - 11:00
Speakers
  • S. Ekman (Solna, Sweden)
Session Name
ESMO Colloquium supported by Eli Lilly & Company - Precision oncology beyond EGFR/ALK for NSCLC in 2023: Test, target, manage (ID 23)
Room
Auditorium 4
Date
Thu, 30.03.2023
Time
09:15 - 10:45
Authors
  • S. Ekman (Solna, Sweden)
ESMO Colloquium

Q&A and discussion

Lecture Time
11:00 - 11:10
Speakers
  • B. Besse (Villejuif, France)
Session Name
ESMO Colloquium supported by Eli Lilly & Company - Precision oncology beyond EGFR/ALK for NSCLC in 2023: Test, target, manage (ID 23)
Room
Auditorium 4
Date
Thu, 30.03.2023
Time
09:15 - 10:45
Authors
  • B. Besse (Villejuif, France)
ESMO Colloquium

Concluding remarks

Lecture Time
11:15 - 11:20
Speakers
  • B. Besse (Villejuif, France)
Session Name
ESMO Colloquium supported by Eli Lilly & Company - Precision oncology beyond EGFR/ALK for NSCLC in 2023: Test, target, manage (ID 23)
Room
Auditorium 4
Date
Thu, 30.03.2023
Time
09:15 - 10:45
Authors
  • B. Besse (Villejuif, France)